The long-term growth prospects of the pharmaceutical sector look promising due to the prevalence of chronic diseases, rising healthcare demands, an aging global population, and advancements in medical research and technological improvements.
Amid this backdrop, it could be wise to buy fundamentally strong pharmaceutical stocks Kamada Ltd. (KMDA), Neurocrine Biosciences, Inc. (NBIX), and Novartis AG (NVS).
